Read how NIBR and Dana-Farber scientists aim to expand immunotherapy options for patients

Jeff Weers’ passion inspired a new way of getting inhaled medicine past the body’s natural defenses to reach the lungs.

Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

Ilona, a patient living with polycythemia vera, shares her experiences with this rare blood cancer

To showcase how people living with ITP triumph and persevere, Novartis partnered with photographer Kate T. Parker on a series of photo essays.

Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.

One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.

From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.